Skip to main content
. 2016 Mar;137(3):e20150463. doi: 10.1542/peds.2015-0463

TABLE 3.

Unadjusted and Adjusted ORs for the Development of Sedation/Anesthesia Adverse Events in the Preterm Category

Event Unadjusted OR OR Adjusted for Age and Gender
OR (95% CI) P OR 95% CI P
Any adverse event 1.87 (1.51–2.31) <.001 1.93 (1.56–2.39) <.001
No adverse event 0.54 (0.43–0.66) <.001 0.52 (0.42–0.64) <.001
Airway obstruction 1.46 (0.93 -2.3) .10 1.58 (1.01–2.49) .045
Oxygen desaturation 2.64 (1.83-3.80) <.001 2.61 (1.81–3.76) <.001
Coughing 1.76 (1.16-2.69) .01 1.59 (1.04–2.43) .03
Secretions 2.78 (1.73–4.48) <.001 2.45 (1.52–3.95) <.001
Agitation 0.63 (0.16–2.53) .48 0.63 (0.16–2.54) .52
Apnea 2.50 (1.46–4.28) .001 3.08 (1.79–5.24) <.001
IV related 1.66 (0.68–4.05) .26 1.36 (0.56–3.30) .51
Hemodynamic change 1.55 (0.49–4.87) .43 1.98 (0.62–6.21) .24
Laryngospasm 0.45 (0.63–3.20) .42 0.44 (0.06–3.12) .41
Vomiting 0.60 (0.08–4.27) .61 0.71 (0.10–5.08) .74
Aspiration 11.8 (1.5–96.1) .02 13.2 (1.57–111.4) .02
Stridor 0.93 (0.13–6.70) .94 0.86 (0.12–6.06) .26
Bronchospasm 2.03 (0.28–14.7) .49 1.57 (0.21–11.5) .66
Emergent airway 0.93 (0.13–6.70) .94 0.95 (0.13–6.81) .95
Hypothermia 33.1 (6.41–170.9) <.001 20.7 (3.90–109.7) <.001
Reversal agent 41.3 (3.74–456.3) .002 46.8 (3.87–565.4) .002
Hiccups 1.06 (0.15–7.62) .96 1.03 (0.14–7.50) .97
Snoring 1.71 (1.08–2.71) .02 1.90 (1.21–3.02) .01

Variables that predicted failure in the model were omitted. P values <0.05 for preterm variable were considered significant. IV, intravenous line.